Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals
Sian Faustini, Adrian Shields, Gemma D. Banham, Nadezhda Wall, Saly Al‐Taei, Chloe Tanner, Zahra Ahmed, Elena Efstathiou, Neal Townsend, Margaret Goodall, Tim Plant, Marisol Pérez-Toledo, Aleksandra Jasiulewicz, Ruth Price, James McLaughlin, John Farnan, Julie Moore, Louise J. Robertson, M. Andrew Nesbit, Grace Curry, Amy Black, Adam F. Cunningham, Lorraine Harper, Tara Moore, Mark T. Drayson, Alex Richter
Topics & Concepts
VirologyGlycoproteinAntibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakImmunologyBiologySpike ProteinMedicineMolecular biologyDiseasePathologyInfectious disease (medical specialty)OutbreakSARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies ResearchImmunotherapy and Immune Responses